Research Article
BibTex RIS Cite

Year 2022, Volume: 43 Issue: 3, 391 - 397, 30.09.2022

Mehmet Abdullah Alagöz İnci Selin Doğan Sıla Sener Zeynep Özdemir

https://doi.org/10.17776/csj.1135400
Cited By: 1

Abstract

References

  • [1] Tang Q.J., Zhang L., Zheng J., Song J., Chen X., Cao W., Xue C., He X., Ma M., Zhao Y., Drug-guided screening for pancreatic lipase inhibitors in functional foods, Food Funct, 12 (2021) 4644-4653.
  • [2] Zechner R., Zimmermann R., Eichmann T.O., Kohlwein S.D., Haemmerle G., Lass A. Madeo F., Fat Signals lipases and lipolysis in lipid metabolism and signaling, Cell metab., 15(2012) 279–291.
  • [3] Bachovchin D.A., Cravatt B.F., The pharmacological landscape and therapeutic potential of serine hydrolases, Nat Rev Drug Discov., 3 (2012) 52-68.
  • [4] Faucher F., Bennett J.M., Bogyo M., Lovell, S., Strategies for Tuning the Selectivity of Chemical Probes that Target Serine Hydrolases, Cell Chem. Biol, 27 (2020) 937-952.
  • [5] Ahmad E.M., Kassab A.E., El-Malah A.A., Hassan M.S.A., Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents, Eur. J. Med. Chem., 171 (2019) 25-37.
  • [6] Gong J., Zheng Y., Wang Y., Sheng W., Li Y., Liu, X. A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway, PLoS ONE, 13 (2018) e0191984.
  • [7] Ramadan S.K., Shaban S.S., Hashem A.I., Facile and expedient synthesis and anti-proliferative activity of diversely pyrrolones bearing 1,3-diphenylpyrazole moiety, Synth. Commun., 55 (2020) 185-196.
  • [8] Dubey S., Bhosle P.A., Pyridazinone: An important element of pharmacophore possessing broad spectrum of activity, Med. Chem. Res., 24 (2015) 3579-3598.
  • [9] Özdemir Z., Başak-Türkmen N., Ayhan İ., Çiftçi O., Uysal M., Synthesis of new 6-[4-(2-fluorophenylpiperazine-1-yl)]-3(2H)-pyridazinone-2-acethyl-2-(substitutedbenzal) hydrazine derivatives and evaluation of their cytotoxic effects in liver and colon cancer cell lines, Pharm. Chem. J., 52 (2019) 923–929.
  • [10] Ciftci O., Özdemir Z., Acar C., Sözen M., Başak-Türkmen N., Ayhan İ., Gözükara H., The novel synthesized pyridazinone derivates had the antiproliferative and apoptotic effects in SHSY5Y and HEP3B cancer cell line, Lett. Org. Chem., 15 (2018) 323–33.
  • [11] Asif M., Abid Imran M., Study of heterocyclic-fused pyridazinone analogues having phosphodiestrase-IV inhibitor activities as anti-inflammatory agents, J. Med. Chem. Sci., 3 (2020) 109-117.
  • [12] Alagöz M.A., Özdemir Z., Uysal M., Carradori S., Gallorini M., Ricci A., Zara S., Mathew B., Synthesis, Cytotoxicity and Anti-Proliferative Activity against AGS Cells of New 3(2H)-Pyridazinone Derivatives Endowed with a Piperazinyl Linker, Pharmaceuticals, 14 (2021) 183.
  • [13] Önkol T., Gökçe M., Orhan İ., Kaynak F., Design, synthesis and evaluation of some novel 3(2H)-pyridazinone-2-yl acetohydrazides as acetylcholinesterase and butyrylcholnesterase inhibitors, Org. Commun., 6 (2013) 55-67.
  • [14] Özçelik A.B., Gökçe M., Orhan İ., Kaynak F., Şahin, M.F., Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory avtivities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone, Arzneim.-Forschung, 60 (2010), 452-458.
  • [15] Bozbey İ., Özdemir Z., Uslu H., Özçelik A.B., Şenol F.S., Erdoğan-Orhan İ., Uysal, M., Mini Rev Med Chem, 20 (2020) 1042.
  • [16] Özdemir Z., Yılmaz H., Sarı S., Karakurt A., Şenol F.S., Uysal M., Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors, Med. Chem. Res., 26 (2017), 2293-308.
  • [17] Özçelik A.B., Özdemir Z., Sari S., Utku S., Uysal, M., A New Series of Pyridazinone Derivatives as Cholinesterases Inhibitors: Synthesis, In Vitro Activity and Molecular Modeling Studies, Pharmacol Rep., 71 (2019) 1253-1263.
  • [18] Kopelman P., Bryson A., Hickling R., Rissanen A., Rossner S., Toubro S., Valensi P., Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients, Int. J. Obes., 31 (2007) 494–499.
  • [19] Point V., Kumar K.V.P.P., Marc S., Delorme V., Parsiegla G., Amara S., Carri`ere F., Buono G., Fotiadu F., Canaan S., Leclaire J., Cavalier J.F., Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones, Eur. J. Med. Chem. 58 (2012) 452–463.
  • [20] Jayanna N.D., Vagdevi H.M., Dharshan J.C., Kekuda T.R.P., Hanumanthappa B. C., Gowdarshivannanavar B.C., Synthesis and biological evaluation of novel 5,7-dichloro-1,3-benzoxazole derivatives, J. Chem. 2013 (2012) 1–9.
  • [21] Kumar A., Chauhan S., Pancreatic lipase inhibitors: The road voyaged and successes, Life Sci., 271 (2021) 119115.
  • [22] Mentes E., Karaali N., Yilmaz F., Ülker S., Kahveci B., Microwave-assisted synthesis and biological evaluation of some benzimidazole derivatives containing a 1,2,4-triazol ring, Arch. Pharm., 346 (2013) 556–561.
  • [23] Bekircan O., Mentes E., Ülker S., Kucuk C., Synthesis of some new 1,2,4-triazole derivatives starting from 3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4- triazol with anti-lipase and anti-urease activities, Arch. Pharm. 347 (2014) 387–397.
  • [24] Evren A.E., Çelik İ., Acar Çevik U., Synthesis, molecular docking, in silico ADME and antimicrobial activity studies of some new benzimidazole-triazole derivatives, CSJ, 42 (2021) 795-805.
  • [25] Sridhar S.N.C., Bhurta D., Kantiwal D., George G., Monga V., Paul A.T., Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors, Bioorganic Med. Chem. Lett., 27 (2017) 3749-3754.
  • [26] Foteini-Nafsika D., Luis A.M., Angel G., Barrie K., Steve P.W., Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2, Platelets, 32 (2021) 744-752.
  • [27] Bivi N., Hu H., Chavali B., Chalmers M.J., Reutter C.T., Durst G.L., Riley A., Sato M., Allen M.R., Burr D.B., Dodge J.A., Structural features underlying raloxifene’s biophysical interaction with bone matrix, Bioorganic Med. Chem., 24 (2016) 759-767.
  • [28] Sable R., Jois S. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors, Molecules, 20 (2015) 11569-11603.
  • [29] Hu B., Cui F., Yin F., Sun Y., Li Y., Caffeoylquinic Acids Competitively Inhibit Pancreatic Lipase through Binding to the Catalytic Triad, Int. J. Biol. Macromol., 80 (2015) 529-535.
  • [30] Halgren T., Murphy R., Friesner R., Beard H., Frye L., Pollard W., Banks J., Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening, J. Med. Chem., 47 (2004). 1750-1759.
  • [31] Kuzu B., Hepokur C., Alagöz M.A., Burmaoglu S., Algul O., Synthesis, Biological Evaluation and In Silico Studies of Some 2-Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer, Chemistry Select, 7 (2022) e20210355.
  • [32] Ersan R.H., Kuzu B., Yetkin D., Alagoz M.A., Dogen A., Burmaoglu S., Algul O., 2-Phenyl substituted Benzimidazole derivatives: Design, synthesis, and evaluation of their antiproliferative and antimicrobial activities, Med. Chem. Res., (2022)
  • [33] Kolinski A., Klein P., Romiszowski P., Skolnick J., Unfolding of globular proteins: monte carlo dynamics of a realistic reduced model, Biophys. J, 85 (2003) 3271–3278.

Synthesis, Molecular Docking and Molecular Dynamics Simulation Studies of Some Pyridazinone Derivatives as Lipase Inhibitors

Year 2022, Volume: 43 Issue: 3, 391 - 397, 30.09.2022

Mehmet Abdullah Alagöz İnci Selin Doğan Sıla Sener Zeynep Özdemir

https://doi.org/10.17776/csj.1135400
Cited By: 1

Abstract

Human health and illness are dependent on lipases, which play a key role in maintaining cell integrity, storing fat for energy and serving as signaling molecules. In this study, 4 compounds that carry 6-phenylpyridazin-3(2H)-one main nucleus, which can be effective as lipase inhibitors, were synthesized and their structures were elucidated. The biological activity of synthesized compounds was evaluated via the porcine pancreatic lipase type II (PLL) inhibitor assay. Orlistat, a lipase inhibitor, was used as a positive control. Compound 8d was found to be the most effective compound, with an IC50 value of 32.66±2.8265 (μg/mL). In addition, molecular docking and molecular dynamics simulations studies were carried out to examine the interactions of the compounds with the target in detail. The results obtained as a result of these in silico studies were found to be compatible with the lipase inhibition effects of the compounds. It was observed that the compounds may have potential lipase inhibitory effects as a result of the substitutions of the 3-(6-oxo-3-phenylpyridazin-1(6H)-yl)propanehydrazide structure.

Keywords

Pyridazinone Molecular docking Molecular dynamics simulations studies Lipase inhibition.

References

  • [1] Tang Q.J., Zhang L., Zheng J., Song J., Chen X., Cao W., Xue C., He X., Ma M., Zhao Y., Drug-guided screening for pancreatic lipase inhibitors in functional foods, Food Funct, 12 (2021) 4644-4653.
  • [2] Zechner R., Zimmermann R., Eichmann T.O., Kohlwein S.D., Haemmerle G., Lass A. Madeo F., Fat Signals lipases and lipolysis in lipid metabolism and signaling, Cell metab., 15(2012) 279–291.
  • [3] Bachovchin D.A., Cravatt B.F., The pharmacological landscape and therapeutic potential of serine hydrolases, Nat Rev Drug Discov., 3 (2012) 52-68.
  • [4] Faucher F., Bennett J.M., Bogyo M., Lovell, S., Strategies for Tuning the Selectivity of Chemical Probes that Target Serine Hydrolases, Cell Chem. Biol, 27 (2020) 937-952.
  • [5] Ahmad E.M., Kassab A.E., El-Malah A.A., Hassan M.S.A., Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents, Eur. J. Med. Chem., 171 (2019) 25-37.
  • [6] Gong J., Zheng Y., Wang Y., Sheng W., Li Y., Liu, X. A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway, PLoS ONE, 13 (2018) e0191984.
  • [7] Ramadan S.K., Shaban S.S., Hashem A.I., Facile and expedient synthesis and anti-proliferative activity of diversely pyrrolones bearing 1,3-diphenylpyrazole moiety, Synth. Commun., 55 (2020) 185-196.
  • [8] Dubey S., Bhosle P.A., Pyridazinone: An important element of pharmacophore possessing broad spectrum of activity, Med. Chem. Res., 24 (2015) 3579-3598.
  • [9] Özdemir Z., Başak-Türkmen N., Ayhan İ., Çiftçi O., Uysal M., Synthesis of new 6-[4-(2-fluorophenylpiperazine-1-yl)]-3(2H)-pyridazinone-2-acethyl-2-(substitutedbenzal) hydrazine derivatives and evaluation of their cytotoxic effects in liver and colon cancer cell lines, Pharm. Chem. J., 52 (2019) 923–929.
  • [10] Ciftci O., Özdemir Z., Acar C., Sözen M., Başak-Türkmen N., Ayhan İ., Gözükara H., The novel synthesized pyridazinone derivates had the antiproliferative and apoptotic effects in SHSY5Y and HEP3B cancer cell line, Lett. Org. Chem., 15 (2018) 323–33.
  • [11] Asif M., Abid Imran M., Study of heterocyclic-fused pyridazinone analogues having phosphodiestrase-IV inhibitor activities as anti-inflammatory agents, J. Med. Chem. Sci., 3 (2020) 109-117.
  • [12] Alagöz M.A., Özdemir Z., Uysal M., Carradori S., Gallorini M., Ricci A., Zara S., Mathew B., Synthesis, Cytotoxicity and Anti-Proliferative Activity against AGS Cells of New 3(2H)-Pyridazinone Derivatives Endowed with a Piperazinyl Linker, Pharmaceuticals, 14 (2021) 183.
  • [13] Önkol T., Gökçe M., Orhan İ., Kaynak F., Design, synthesis and evaluation of some novel 3(2H)-pyridazinone-2-yl acetohydrazides as acetylcholinesterase and butyrylcholnesterase inhibitors, Org. Commun., 6 (2013) 55-67.
  • [14] Özçelik A.B., Gökçe M., Orhan İ., Kaynak F., Şahin, M.F., Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory avtivities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone, Arzneim.-Forschung, 60 (2010), 452-458.
  • [15] Bozbey İ., Özdemir Z., Uslu H., Özçelik A.B., Şenol F.S., Erdoğan-Orhan İ., Uysal, M., Mini Rev Med Chem, 20 (2020) 1042.
  • [16] Özdemir Z., Yılmaz H., Sarı S., Karakurt A., Şenol F.S., Uysal M., Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors, Med. Chem. Res., 26 (2017), 2293-308.
  • [17] Özçelik A.B., Özdemir Z., Sari S., Utku S., Uysal, M., A New Series of Pyridazinone Derivatives as Cholinesterases Inhibitors: Synthesis, In Vitro Activity and Molecular Modeling Studies, Pharmacol Rep., 71 (2019) 1253-1263.
  • [18] Kopelman P., Bryson A., Hickling R., Rissanen A., Rossner S., Toubro S., Valensi P., Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients, Int. J. Obes., 31 (2007) 494–499.
  • [19] Point V., Kumar K.V.P.P., Marc S., Delorme V., Parsiegla G., Amara S., Carri`ere F., Buono G., Fotiadu F., Canaan S., Leclaire J., Cavalier J.F., Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones, Eur. J. Med. Chem. 58 (2012) 452–463.
  • [20] Jayanna N.D., Vagdevi H.M., Dharshan J.C., Kekuda T.R.P., Hanumanthappa B. C., Gowdarshivannanavar B.C., Synthesis and biological evaluation of novel 5,7-dichloro-1,3-benzoxazole derivatives, J. Chem. 2013 (2012) 1–9.
  • [21] Kumar A., Chauhan S., Pancreatic lipase inhibitors: The road voyaged and successes, Life Sci., 271 (2021) 119115.
  • [22] Mentes E., Karaali N., Yilmaz F., Ülker S., Kahveci B., Microwave-assisted synthesis and biological evaluation of some benzimidazole derivatives containing a 1,2,4-triazol ring, Arch. Pharm., 346 (2013) 556–561.
  • [23] Bekircan O., Mentes E., Ülker S., Kucuk C., Synthesis of some new 1,2,4-triazole derivatives starting from 3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4- triazol with anti-lipase and anti-urease activities, Arch. Pharm. 347 (2014) 387–397.
  • [24] Evren A.E., Çelik İ., Acar Çevik U., Synthesis, molecular docking, in silico ADME and antimicrobial activity studies of some new benzimidazole-triazole derivatives, CSJ, 42 (2021) 795-805.
  • [25] Sridhar S.N.C., Bhurta D., Kantiwal D., George G., Monga V., Paul A.T., Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors, Bioorganic Med. Chem. Lett., 27 (2017) 3749-3754.
  • [26] Foteini-Nafsika D., Luis A.M., Angel G., Barrie K., Steve P.W., Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2, Platelets, 32 (2021) 744-752.
  • [27] Bivi N., Hu H., Chavali B., Chalmers M.J., Reutter C.T., Durst G.L., Riley A., Sato M., Allen M.R., Burr D.B., Dodge J.A., Structural features underlying raloxifene’s biophysical interaction with bone matrix, Bioorganic Med. Chem., 24 (2016) 759-767.
  • [28] Sable R., Jois S. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors, Molecules, 20 (2015) 11569-11603.
  • [29] Hu B., Cui F., Yin F., Sun Y., Li Y., Caffeoylquinic Acids Competitively Inhibit Pancreatic Lipase through Binding to the Catalytic Triad, Int. J. Biol. Macromol., 80 (2015) 529-535.
  • [30] Halgren T., Murphy R., Friesner R., Beard H., Frye L., Pollard W., Banks J., Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening, J. Med. Chem., 47 (2004). 1750-1759.
  • [31] Kuzu B., Hepokur C., Alagöz M.A., Burmaoglu S., Algul O., Synthesis, Biological Evaluation and In Silico Studies of Some 2-Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer, Chemistry Select, 7 (2022) e20210355.
  • [32] Ersan R.H., Kuzu B., Yetkin D., Alagoz M.A., Dogen A., Burmaoglu S., Algul O., 2-Phenyl substituted Benzimidazole derivatives: Design, synthesis, and evaluation of their antiproliferative and antimicrobial activities, Med. Chem. Res., (2022)
  • [33] Kolinski A., Klein P., Romiszowski P., Skolnick J., Unfolding of globular proteins: monte carlo dynamics of a realistic reduced model, Biophys. J, 85 (2003) 3271–3278.
There are 33 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences
Journal Section Natural Sciences
Authors

Mehmet Abdullah Alagöz 0000-0001-5190-7196

İnci Selin Doğan 0000-0003-4949-1747

Sıla Sener 0000-0001-7679-7165

Zeynep Özdemir 0000-0003-4559-2305

Publication Date September 30, 2022
Submission Date June 24, 2022
Acceptance Date August 26, 2022
Published in Issue Year 2022Volume: 43 Issue: 3

Cite

APA Alagöz, M. A., Doğan, İ. S., Sener, S., Özdemir, Z. (2022). Synthesis, Molecular Docking and Molecular Dynamics Simulation Studies of Some Pyridazinone Derivatives as Lipase Inhibitors. Cumhuriyet Science Journal, 43(3), 391-397. https://doi.org/10.17776/csj.1135400

Cited By

Design, Synthesis, Molecular Modelling and in Vitro Evaluation of Indolyl Ketohydrazide‐Hydrazone Analogs as Potential Pancreatic Lipase Inhibitors
Chemistry & Biodiversity
https://doi.org/10.1002/cbdv.202301154
 Download Cover Image